| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/14/1997 | EP0772681A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 05/14/1997 | EP0772679A1 Schistosoma protein and uses thereof |
| 05/14/1997 | EP0772678A1 Modulation of drug radiation resistant genes |
| 05/14/1997 | EP0772677A1 T cell activation |
| 05/14/1997 | EP0772631A1 Processes for the purification of human recombinant decorin and the detection of guanidinium ions |
| 05/14/1997 | EP0772630A1 Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same |
| 05/14/1997 | EP0772629A1 T cell epitopes of rye grass pollen allergen |
| 05/14/1997 | EP0772627A1 Production of biologically active recombinant neurotrophic protein |
| 05/14/1997 | EP0772626A1 Isolated nucleic acid sequence coding for a tumor rejection antigen presented by hla-a2 |
| 05/14/1997 | EP0772625A1 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis |
| 05/14/1997 | EP0772624A1 Interleukin-15 |
| 05/14/1997 | EP0772621A2 Oligonucleotides with anti-mdr-1 gene activity |
| 05/14/1997 | EP0772620A1 Antimessenger oligonucleotides and urokinase receptor reversion of the invasive phenotype of transformed human fibroblasts by antimessenger oligonucleotide inhibition of urokinase receptor gene expression |
| 05/14/1997 | EP0772466A1 Compositions and methods for a bioartificial extracellular matrix |
| 05/14/1997 | EP0772455A2 Intracellular expression of carboxypeptidase g2 in enzyme prodrug therapy |
| 05/14/1997 | EP0772454A1 Antisense oligonucleotides against hepatitis b viral replication |
| 05/14/1997 | EP0772452A1 Pharmaceutical formulation for subcutaneous, intramuscular or intradermal administration of factor viii or factor ix |
| 05/14/1997 | EP0772451A1 Treatment of type ii diabetes mellitus with amylin agonists |
| 05/14/1997 | EP0772450A1 Methods for treating bleeding disorders |
| 05/14/1997 | EP0772449A1 Pharmaceutical compositions comprising a chimaeric tnf binding protein |
| 05/14/1997 | EP0772448A1 CYCLIC ANALOGS OF PTH AND PTHrP |
| 05/14/1997 | EP0772442A1 Use of immunosuppressive agents for the treatment of schizophrenia |
| 05/14/1997 | EP0772437A1 Compositions and methods for delivery of genetic material |
| 05/14/1997 | EP0772436A1 Incorporation of biologically active molecules into bioactive glasses |
| 05/14/1997 | EP0772435A1 Controlled release of metal cation-stabilized interferon |
| 05/14/1997 | EP0772396A1 Method of regulating immune function |
| 05/14/1997 | EP0644894B1 Peptide for stimulation of cytotoxic t lymphocytes specific for hepatitis c virus |
| 05/14/1997 | EP0603305B1 Use of a thymosin in the treatment of hepatitis c |
| 05/14/1997 | EP0495131B1 Agent for preventing and treating hepatitis |
| 05/14/1997 | EP0441947B1 Neurotrophin-3, a novel neurotrophic factor related to nerve growth factor and brain derived neurotrophic factor |
| 05/14/1997 | CN1149887A Compounds and methods for stimulation and enhancement of protective immune responses and IL-12 production |
| 05/14/1997 | CN1149877A Novel elastase inhibitor |
| 05/14/1997 | CN1149876A Perfluoroalkyl ketone inhibitors of elastase and processes for making same |
| 05/14/1997 | CN1149834A Cyclosporin containing composition and process for preparation |
| 05/14/1997 | CN1149833A Acylated enol derivatives as prodrugs of elastase inhibitors |
| 05/14/1997 | CN1149822A Therapeutical homeopathic dilutions of growth factors and methods of their use |
| 05/14/1997 | CN1149588A Cyclic bonding inhibitor |
| 05/14/1997 | CN1034869C Peptide compound and its preparing method for pharmaceutical salt |
| 05/13/1997 | US5629431 Inhibitors of retroviral proteases |
| 05/13/1997 | US5629415 Genetic engineering |
| 05/13/1997 | US5629408 Immunochemical isolation of in vivo advanced glycosylation endproducts |
| 05/13/1997 | US5629407 DNA encoding an 18 KD CDK6 inhibiting protein and antibodies thereto |
| 05/13/1997 | US5629406 Amino acid derivatives |
| 05/13/1997 | US5629347 Aromatic compounds, pharmaceutical compositions containing them and their use in therapy |
| 05/13/1997 | US5629327 Methods and compositions for inhibition of angiogenesis |
| 05/13/1997 | US5629319 Quindoline alkaloids |
| 05/13/1997 | US5629309 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ACE |
| 05/13/1997 | US5629294 Compositions and methods for preventing adhesion formation |
| 05/13/1997 | US5629293 Single chain peptide compounds having hemoregulatory activity |
| 05/13/1997 | US5629292 Use of angiotensin III and analogs thereof in tissue repair |
| 05/13/1997 | US5629291 Methods of modulating fibronectin extracellular matrix assembly |
| 05/13/1997 | US5629290 Cyclic peptide antifungal agents |
| 05/13/1997 | US5629289 Cyclic peptide antifungal agents |
| 05/13/1997 | US5629288 Lipopeptide derivatives, a process for their preparation and their use |
| 05/13/1997 | US5629287 Depot formulations |
| 05/13/1997 | US5629286 Homeopathic dilutions of growth factors |
| 05/13/1997 | US5629285 Inhibitors of TNF-α secretion |
| 05/13/1997 | US5629284 Method for treating retinal diseases |
| 05/13/1997 | US5629283 Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 05/13/1997 | US5629282 Antibacterial compositions |
| 05/13/1997 | US5629204 Peptide related to human programmed cell death and DNA encoding it |
| 05/13/1997 | US5629198 Porphyrin derivative |
| 05/13/1997 | US5629197 Monoclonal anti-human breast cancer antibodies |
| 05/13/1997 | US5629193 Paraoxonase |
| 05/13/1997 | US5629192 ETS1 gene: a human tumor suppressor gene |
| 05/13/1997 | US5629176 Dna construct comprising dna sequence encoding the variant; recombinant expression vector comprising the construct; host cell containing the construct or vector; culture process for making the variant; pharmaceutical comprising the variant |
| 05/13/1997 | US5629174 Dna, rna |
| 05/13/1997 | US5629167 Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay |
| 05/13/1997 | US5629166 Cancer diagnosis |
| 05/13/1997 | US5629165 Calpastatins, detection of neurodegenerative conditions such as alzheimer*s disease by reaction with antibody |
| 05/13/1997 | US5629162 Method of identifying agents which modulate ICAM-3 binding to LFA-1 |
| 05/13/1997 | US5629159 Immortalization and disimmortalization of cells |
| 05/13/1997 | US5629155 High-affinity oligonucleotide ligands to immunoglobulin E (IgE) |
| 05/13/1997 | US5629154 Telomerase activity assays |
| 05/13/1997 | US5629023 Nutrient composition increases hepatic detoxifying ability of the liver |
| 05/13/1997 | US5629020 Delivery of sensitive agents such as bioactive peptides |
| 05/13/1997 | US5629001 Oral administration of therapeutic proteins for treatment of infectious disease |
| 05/13/1997 | US5628999 Hypoglycemic agent from cryptolepis |
| 05/13/1997 | US5628996 Method for inhibiting the viability of Pseudomonas aeruginosa with cross-reactive and cross-protective monoclonal antibodies |
| 05/13/1997 | US5628993 Interferon and polyglycerol diester of stearic acid or palmitic acid |
| 05/13/1997 | US5628979 Reagent for tumor imaging and therapy |
| 05/10/1997 | CA2190296A1 Factors and methods for reducing biological activity of a multimeric protein and methods of screening therefor |
| 05/09/1997 | WO1997016727A1 Assay background reduction using glycoproteins with oxidized carbohydrates |
| 05/09/1997 | WO1997016557A1 TREATMENT OF TUMOURS BY ADOPTIVE TRANSFER OF CD44v-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
| 05/09/1997 | WO1997016556A1 Rationally designed polysaccharide lyases derived from heparinase i |
| 05/09/1997 | WO1997016550A1 Polypeptide fragments derived from the obese gene product |
| 05/09/1997 | WO1997016549A2 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 05/09/1997 | WO1997016548A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS |
| 05/09/1997 | WO1997016547A1 ADENOVIRUS-ANTISENSE K-ras EXPRESSION VECTORS AND THEIR APPLICATION IN CANCER THERAPY |
| 05/09/1997 | WO1997016542A1 Diagnostics and treatments of periodontal disease |
| 05/09/1997 | WO1997016535A2 METHODS FOR USE OF Mpl LIGANDS WITH PRIMITIVE HUMAN STEM CELLS |
| 05/09/1997 | WO1997016532A1 Immunity against actinobacillus pleuropneumoniae's rtx toxins apx |
| 05/09/1997 | WO1997016531A1 Immunity against pasteurella haemolytica leukotoxin |
| 05/09/1997 | WO1997016460A1 Casein fragments having growth promoting activity |
| 05/09/1997 | WO1997016459A1 Use of protein gax for treating cancer |
| 05/09/1997 | WO1997016458A1 Apolipoprotein e2 and treatment of alzheimer's disease |
| 05/09/1997 | WO1997016457A2 Anti-tumoral protein |
| 05/09/1997 | WO1997016438A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | WO1997016437A1 Triterpene derivatives with immunosuppressant activity |
| 05/09/1997 | WO1997016433A1 Protease inhibitors |